Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/1998
12/02/1998EP0869975A4 Assay for and uses of peptide hormone receptor ligands
12/02/1998EP0804466B1 Novel tetrapeptides, their manufacture and use
12/02/1998EP0771210A4 TWO NON-CONTIGUOUS REGIONS CONTRIBUTE TO NIDOGEN BINDING TO A SINGLE EGF-LIKE MOTIF OF THE LAMININ -g(g)1 CHAIN
12/02/1998EP0752875A4 Glioblastoma-derived angiogenesis inhibiting factor
12/02/1998EP0542887B1 Psoralen conjugated methylphosphonate oligonucleotides as therapeutic agents for chronic myelogenous leukemia
12/02/1998CN1200737A Recombinant anti-CD4 antibodies for human therapy
12/02/1998CN1200732A Farnesyl transferase inhibiting 2-quinolone derivatives
12/02/1998CN1200669A Oral gel capsule formulation of 1,2,4-benzotriazine oxides
12/02/1998CN1200653A Cancer chemoprotective food products
12/02/1998CN1200374A Vitronectin receptor antagonists, their prepn. and their use
12/02/1998CN1200373A Vitronectin receptor antagonists, their prepn. and use
12/02/1998CN1200272A Immunologic facilitation agent for inhibiting growth of tumor
12/02/1998CN1200266A Method for preparing anti-cancer medicine using beta-elemene as main effective ingredient, and components of the medicine
12/02/1998CN1040982C Method for preparing pyranoquinoline and salts thereof
12/02/1998CN1040980C Second messenger cell signaling inhibitors
12/02/1998CA2230963A1 A human 7-tm receptor similar to murine frizzled-6 gene
12/01/1998US5844106 Modified oligonucleotides, their preparation and their use
12/01/1998US5844099 Cytokine antagonists
12/01/1998US5844093 Anti-EGFR single-chain Fvs and anti-EGFR antibodies
12/01/1998US5844092 Human TRK receptors and neurotrophic factor inhibitors
12/01/1998US5844075 Melanoma antigens and their use in diagnostic and therapeutic methods
12/01/1998US5844074 Cyclic CRF agonists
12/01/1998US5843994 Compositions and methods for treating and preventing pathologies including cancer
12/01/1998US5843986 Tricyclic amide compounds
12/01/1998US5843984 Sulfated benzothiophene derivatives, methods of use and formulations containing same
12/01/1998US5843974 Methods of inhibiting melanoma using Benzothiophenes as cytotoxic agents per se
12/01/1998US5843954 Camptothecin derivatives, preparations thereof and antitumor agents
12/01/1998US5843941 Ras farnesyl transferase inhibitors
12/01/1998US5843940 Benzothiophene compounds, compositions, and method
12/01/1998US5843939 Derivatives of 3-bromo- and 3,3-dibromo-4-oxo-1-azetidines, processes for the preparation thereof and their use
12/01/1998US5843937 DNA-binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents
12/01/1998US5843935 Protein kinase C inhibitors
12/01/1998US5843927 18,19-dinor-vitamin D compounds
12/01/1998US5843924 Intravenous alendronate formulations
12/01/1998US5843917 5-Fluorouracil derivatives
12/01/1998US5843910 Colchicine derivatives and the therapeutical use thereof
12/01/1998US5843906 Meta-substituted phenylene sulphonamide derivatives
12/01/1998US5843904 Inhibitors of interleukin-1βconverting enzyme
12/01/1998US5843903 Targeted cytotoxic anthracycline analogs
12/01/1998US5843901 LHRH antagonist peptides
12/01/1998US5843894 Methods for reduced renal uptake of antibody fragments
12/01/1998US5843883 Methods of wound healing and treating hyperproliferative diseases of epidermis comprising administering trunicated keratinocyte growh factor (KGF) having increased biological activity
12/01/1998US5843773 Apoptosis regulating gene
12/01/1998US5843727 Polynucleotides encoding a human tumor-associated membrane protein
12/01/1998US5843719 Cellubrevin homolog
12/01/1998US5843687 Isolated, tyrosinase derived peptides and uses thereof
12/01/1998US5843686 Methods of diagnosing metastatic cancer with MTS-1 protein
12/01/1998US5843665 Human pyrophosphatase
12/01/1998US5843481 Treatment of proliferative disorders, metastasaes, and drug resistant tumors with vanadate compounds and derivatives or analogues thereof
12/01/1998US5843475 Delivery and activation through liposome incorporation of diaminocyclohexane platinum (II) complexes
12/01/1998US5843448 Tumor rejection antigen precursor
12/01/1998US5843439 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
12/01/1998US5843438 Peripheralization of hematopoietic stem cells
12/01/1998US5843435 Immunotherapy of cancer with allogeneic lymphocytes
12/01/1998US5843432 Retroviral vectors for the treatment of tumors, and cell lines containing them
12/01/1998US5843423 Methods of stimulating hematopoietic cells with flt3-ligand
12/01/1998US5843422 Method and compositions for treating injury
11/1998
11/30/1998CA2233554A1 Novel compounds
11/29/1998CA2231723A1 Novel has2 splicing variant hoefc11: a target in chronic renal failure, inflammatory diseases and myocardial schemia
11/26/1998WO1998053079A1 Ubiquitin conjugation proteins
11/26/1998WO1998053065A1 Human semaphorin e and polynucleotides encoding it
11/26/1998WO1998053051A1 Short peptides which selectively modulate intracellular signalling
11/26/1998WO1998053050A2 Short peptides which selectively modulate the activity of serine/threonine kinases
11/26/1998WO1998052947A1 Process for preparing 6-o-monoesters of castanospermine
11/26/1998WO1998052935A1 Substituted heterocyclic compounds, method for preparing and compositions containing same
11/26/1998WO1998052925A1 Analogs of duocarmycin and cc-1065
11/26/1998WO1998052914A1 Leukotriene b4 derivatives, in particular 7-methylcyclohexyl-ltb4 antagonists
11/26/1998WO1998052910A1 Metalloproteinase inhibitors
11/26/1998WO1998052894A1 Cyclohexanediol derivatives
11/26/1998WO1998052609A1 Sonodynamic therapy using an ultrasound sensitizer compound
11/26/1998WO1998052597A1 Apoptosis-inducing gelsolin sequences
11/26/1998WO1998052591A1 Glial cell line-derived neurotrophic factor receptors
11/26/1998WO1998052578A1 Fructan containing composition for the prevention and treatment of colon cancer
11/26/1998WO1998052577A1 Ganglioside gm3 induced apoptosis of neural cells
11/26/1998WO1998052562A1 Pharmaceutical composition containing uscharidin or its analogues
11/26/1998WO1998052559A1 Raf kinase inhibitors
11/26/1998WO1998052558A1 INHIBITION OF p38 KINASE ACTIVITY BY ARYL UREAS
11/26/1998WO1998052553A1 Methods for treatment of conditions associated with lactosylceramide
11/26/1998WO1998052551A1 Bisaryl compounds and cancer remedies containing the same
11/26/1998WO1998036776A3 Gel delivery vehicles for anticellular proliferative agents
11/26/1998WO1998035554A3 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
11/26/1998WO1998031800A3 Human proteins
11/26/1998CA2291710A1 Bisaryl compounds and cancer remedies containing the same
11/26/1998CA2291477A1 Human semaphorin e and polynucleotides encoding it
11/26/1998CA2291169A1 Metalloproteinase inhibitors
11/26/1998CA2291132A1 Pharmaceutical composition containing uscharidin or its analogues
11/26/1998CA2291112A1 Leukotriene b4 derivatives, in particular 7-methylcyclohexyl-ltb4 antagonists
11/26/1998CA2290825A1 Short peptides which selectively modulate intracellular signalling
11/26/1998CA2290789A1 Analogs of duocarmycin and cc-1065
11/26/1998CA2290769A1 Ubiquitin conjugation proteins
11/26/1998CA2290721A1 Short peptides which selectively modulate the activity of serine/threonine kinases
11/26/1998CA2290598A1 Ganglioside gm3 induced apoptosis of neural cells
11/26/1998CA2290426A1 Glial cell line-derived neurotrophic factor receptors
11/26/1998CA2288629A1 Cyclohexanediol derivatives
11/25/1998EP0879889A2 A novel member of the IL-1 family, IL-1 delta
11/25/1998EP0879888A2 Patched-2 polypeptides and polynucleotides and methods for their production
11/25/1998EP0879883A1 ATG-1120 (AIF-1-DELTA), a splice variant of AIF-1/RC-9
11/25/1998EP0879882A1 ATG-1100 (AIF-1-Gamma), a splice variant of AIF-1/RC-9
11/25/1998EP0879880A1 ATG-1117 (AIF-3), a homolog of allograft inflammatory factor-1/RC-9
11/25/1998EP0879820A1 Benzamide analogues, useful as PARP (ADP-Ribosyltransferase, ADPRT) DNA repair enzyme inhibitors
1 ... 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 ... 2211